ID   INSRR_HUMAN             Reviewed;        1297 AA.
AC   P14616; O60724; Q5VZS3;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   12-OCT-2022, entry version 204.
DE   RecName: Full=Insulin receptor-related protein;
DE            Short=IRR;
DE            EC=2.7.10.1;
DE   AltName: Full=IR-related receptor;
DE   Contains:
DE     RecName: Full=Insulin receptor-related protein alpha chain;
DE   Contains:
DE     RecName: Full=Insulin receptor-related protein beta chain;
DE   Flags: Precursor;
GN   Name=INSRR; Synonyms=IRR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=10226785; DOI=10.1055/s-2007-978702;
RA   Haenze J., Berthold A., Klammt J., Gallaher B., Siebler T., Kratzsch J.,
RA   Elmlinger M., Kiess W.;
RT   "Cloning and sequencing of the complete cDNA encoding the human insulin
RT   receptor related receptor.";
RL   Horm. Metab. Res. 31:77-79(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-1297.
RX   PubMed=2768234; DOI=10.1016/s0021-9258(18)63737-8;
RA   Shier P., Watt V.M.;
RT   "Primary structure of a putative receptor for a ligand of the insulin
RT   family.";
RL   J. Biol. Chem. 264:14605-14608(1989).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-127; VAL-161; HIS-244; ARG-246;
RP   GLN-278; CYS-554; LEU-928 AND GLU-1065.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [6]
RP   FUNCTION, MUTAGENESIS OF 1145-TYR-TYR-1146, AND AUTOPHOSPHORYLATION.
RX   PubMed=21641549; DOI=10.1016/j.cmet.2011.03.022;
RA   Deyev I.E., Sohet F., Vassilenko K.P., Serova O.V., Popova N.V.,
RA   Zozulya S.A., Burova E.B., Houillier P., Rzhevsky D.I., Berchatova A.A.,
RA   Murashev A.N., Chugunov A.O., Efremov R.G., Nikol'sky N.N., Bertelli E.,
RA   Eladari D., Petrenko A.G.;
RT   "Insulin receptor-related receptor as an extracellular alkali sensor.";
RL   Cell Metab. 13:679-689(2011).
CC   -!- FUNCTION: Receptor with tyrosine-protein kinase activity. Functions as
CC       a pH sensing receptor which is activated by increased extracellular pH.
CC       Activates an intracellular signaling pathway that involves IRS1 and
CC       AKT1/PKB. {ECO:0000269|PubMed:21641549}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Probable tetramer of 2 alpha and 2 beta chains linked by
CC       disulfide bonds. The alpha chains contribute to the formation of the
CC       ligand-binding domain, while the beta chains carry the kinase domain.
CC   -!- INTERACTION:
CC       P14616; P08238: HSP90AB1; NbExp=3; IntAct=EBI-6424336, EBI-352572;
CC       P14616; P06213: INSR; NbExp=4; IntAct=EBI-6424336, EBI-475899;
CC       P14616; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-6424336, EBI-16439278;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- DOMAIN: The extracellular domain is required for sensing alterations in
CC       external pH.
CC   -!- PTM: Autophosphorylated on tyrosine residues between pH 7.9 and pH
CC       10.5.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF064078; AAC17167.1; -; mRNA.
DR   EMBL; AL158169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52903.1; -; Genomic_DNA.
DR   EMBL; J05046; AAC31759.1; -; mRNA.
DR   CCDS; CCDS1160.1; -.
DR   PIR; B36502; B36502.
DR   RefSeq; NP_055030.1; NM_014215.2.
DR   AlphaFoldDB; P14616; -.
DR   SASBDB; P14616; -.
DR   SMR; P14616; -.
DR   BioGRID; 109856; 60.
DR   IntAct; P14616; 39.
DR   MINT; P14616; -.
DR   STRING; 9606.ENSP00000357178; -.
DR   BindingDB; P14616; -.
DR   ChEMBL; CHEMBL5483; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; P14616; -.
DR   GuidetoPHARMACOLOGY; 1802; -.
DR   GlyGen; P14616; 10 sites.
DR   iPTMnet; P14616; -.
DR   PhosphoSitePlus; P14616; -.
DR   BioMuta; INSRR; -.
DR   DMDM; 12644000; -.
DR   EPD; P14616; -.
DR   jPOST; P14616; -.
DR   MassIVE; P14616; -.
DR   MaxQB; P14616; -.
DR   PaxDb; P14616; -.
DR   PeptideAtlas; P14616; -.
DR   PRIDE; P14616; -.
DR   Antibodypedia; 20446; 394 antibodies from 33 providers.
DR   DNASU; 3645; -.
DR   Ensembl; ENST00000368195.4; ENSP00000357178.3; ENSG00000027644.5.
DR   GeneID; 3645; -.
DR   KEGG; hsa:3645; -.
DR   MANE-Select; ENST00000368195.4; ENSP00000357178.3; NM_014215.3; NP_055030.1.
DR   UCSC; uc010pht.3; human.
DR   CTD; 3645; -.
DR   DisGeNET; 3645; -.
DR   GeneCards; INSRR; -.
DR   HGNC; HGNC:6093; INSRR.
DR   HPA; ENSG00000027644; Group enriched (brain, kidney).
DR   MIM; 147671; gene.
DR   neXtProt; NX_P14616; -.
DR   OpenTargets; ENSG00000027644; -.
DR   PharmGKB; PA29899; -.
DR   VEuPathDB; HostDB:ENSG00000027644; -.
DR   eggNOG; KOG1095; Eukaryota.
DR   eggNOG; KOG4258; Eukaryota.
DR   GeneTree; ENSGT00940000160437; -.
DR   HOGENOM; CLU_000288_166_0_1; -.
DR   InParanoid; P14616; -.
DR   OMA; GTRGRWQ; -.
DR   OrthoDB; 750182at2759; -.
DR   PhylomeDB; P14616; -.
DR   TreeFam; TF351636; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   PathwayCommons; P14616; -.
DR   SignaLink; P14616; -.
DR   BioGRID-ORCS; 3645; 12 hits in 1097 CRISPR screens.
DR   GeneWiki; INSRR; -.
DR   GenomeRNAi; 3645; -.
DR   Pharos; P14616; Tchem.
DR   PRO; PR:P14616; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P14616; protein.
DR   Bgee; ENSG00000027644; Expressed in adult mammalian kidney and 60 other tissues.
DR   Genevisible; P14616; HS.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005899; C:insulin receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005009; F:insulin receptor activity; IBA:GO_Central.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IBA:GO_Central.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
DR   GO; GO:0071469; P:cellular response to alkaline pH; IDA:UniProtKB.
DR   GO; GO:0030238; P:male sex determination; IEA:Ensembl.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd00063; FN3; 3.
DR   CDD; cd00064; FU; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.80.20.20; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR028792; INSRR.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016246; Tyr_kinase_insulin-like_rcpt.
DR   InterPro; IPR002011; Tyr_kinase_rcpt_2_CS.
DR   PANTHER; PTHR24416:SF338; PTHR24416:SF338; 1.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   PIRSF; PIRSF000620; Insulin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00261; FU; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cleavage on pair of basic residues; Disulfide bond;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..1297
FT                   /note="Insulin receptor-related protein"
FT                   /id="PRO_0000016701"
FT   CHAIN           27..742
FT                   /note="Insulin receptor-related protein alpha chain"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000016702"
FT   CHAIN           747..1297
FT                   /note="Insulin receptor-related protein beta chain"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000016703"
FT   TOPO_DOM        747..921
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        922..943
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        944..1297
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          483..603
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          607..707
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          818..913
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          979..1254
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          666..687
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          732..758
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1267..1297
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1275..1289
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1115
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         985..993
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         1013
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         1145
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         1146
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000305"
FT   CARBOHYD        47
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        311
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        411
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        492
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        528
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        616
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        634
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        756
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        885
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        898
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        214..222
FT                   /evidence="ECO:0000250"
FT   DISULFID        216..228
FT                   /evidence="ECO:0000250"
FT   DISULFID        229..237
FT                   /evidence="ECO:0000250"
FT   DISULFID        233..246
FT                   /evidence="ECO:0000250"
FT   DISULFID        249..258
FT                   /evidence="ECO:0000250"
FT   DISULFID        262..274
FT                   /evidence="ECO:0000250"
FT   DISULFID        280..300
FT                   /evidence="ECO:0000250"
FT   DISULFID        304..317
FT                   /evidence="ECO:0000250"
FT   DISULFID        320..324
FT                   /evidence="ECO:0000250"
FT   DISULFID        657..864
FT                   /note="Interchain (between alpha and beta chains)"
FT                   /evidence="ECO:0000255"
FT   VARIANT         127
FT                   /note="A -> E (in dbSNP:rs55757706)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041434"
FT   VARIANT         161
FT                   /note="A -> V (in dbSNP:rs55971900)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041435"
FT   VARIANT         244
FT                   /note="R -> H (in dbSNP:rs55951840)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041436"
FT   VARIANT         246
FT                   /note="C -> R (in dbSNP:rs56377825)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041437"
FT   VARIANT         278
FT                   /note="E -> Q (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041438"
FT   VARIANT         554
FT                   /note="R -> C (in dbSNP:rs56068937)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041439"
FT   VARIANT         928
FT                   /note="P -> L (in dbSNP:rs56252149)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041440"
FT   VARIANT         1065
FT                   /note="G -> E (in a glioblastoma multiforme sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041441"
FT   MUTAGEN         1145..1146
FT                   /note="YY->FF: Abolishes autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:21641549"
SQ   SEQUENCE   1297 AA;  143720 MW;  BB22C7FF61E3065D CRC64;
     MAVPSLWPWG ACLPVIFLSL GFGLDTVEVC PSLDIRSEVA ELRQLENCSV VEGHLQILLM
     FTATGEDFRG LSFPRLTQVT DYLLLFRVYG LESLRDLFPN LAVIRGTRLF LGYALVIFEM
     PHLRDVALPA LGAVLRGAVR VEKNQELCHL STIDWGLLQP APGANHIVGN KLGEECADVC
     PGVLGAAGEP CAKTTFSGHT DYRCWTSSHC QRVCPCPHGM ACTARGECCH TECLGGCSQP
     EDPRACVACR HLYFQGACLW ACPPGTYQYE SWRCVTAERC ASLHSVPGRA STFGIHQGSC
     LAQCPSGFTR NSSSIFCHKC EGLCPKECKV GTKTIDSIQA AQDLVGCTHV EGSLILNLRQ
     GYNLEPQLQH SLGLVETITG FLKIKHSFAL VSLGFFKNLK LIRGDAMVDG NYTLYVLDNQ
     NLQQLGSWVA AGLTIPVGKI YFAFNPRLCL EHIYRLEEVT GTRGRQNKAE INPRTNGDRA
     ACQTRTLRFV SNVTEADRIL LRWERYEPLE ARDLLSFIVY YKESPFQNAT EHVGPDACGT
     QSWNLLDVEL PLSRTQEPGV TLASLKPWTQ YAVFVRAITL TTEEDSPHQG AQSPIVYLRT
     LPAAPTVPQD VISTSNSSSH LLVRWKPPTQ RNGNLTYYLV LWQRLAEDGD LYLNDYCHRG
     LRLPTSNNDP RFDGEDGDPE AEMESDCCPC QHPPPGQVLP PLEAQEASFQ KKFENFLHNA
     ITIPISPWKV TSINKSPQRD SGRHRRAAGP LRLGGNSSDF EIQEDKVPRE RAVLSGLRHF
     TEYRIDIHAC NHAAHTVGCS AATFVFARTM PHREADGIPG KVAWEASSKN SVLLRWLEPP
     DPNGLILKYE IKYRRLGEEA TVLCVSRLRY AKFGGVHLAL LPPGNYSARV RATSLAGNGS
     WTDSVAFYIL GPEEEDAGGL HVLLTATPVG LTLLIVLAAL GFFYGKKRNR TLYASVNPEY
     FSASDMYVPD EWEVPREQIS IIRELGQGSF GMVYEGLARG LEAGEESTPV ALKTVNELAS
     PRECIEFLKE ASVMKAFKCH HVVRLLGVVS QGQPTLVIME LMTRGDLKSH LRSLRPEAEN
     NPGLPQPALG EMIQMAGEIA DGMAYLAANK FVHRDLAARN CMVSQDFTVK IGDFGMTRDV
     YETDYYRKGG KGLLPVRWMA PESLKDGIFT THSDVWSFGV VLWEIVTLAE QPYQGLSNEQ
     VLKFVMDGGV LEELEGCPLQ LQELMSRCWQ PNPRLRPSFT HILDSIQEEL RPSFRLLSFY
     YSPECRGARG SLPTTDAEPD SSPTPRDCSP QNGGPGH
//
